#news #biotech Medigene shares sag as it axes TCR-T blood cancer drug, with COVID-19 partly to blame

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Medigene shares sag as it axes TCR-T blood cancer drug, with COVID-19 partly to blame .Medigene shares sag as it axes TCR-T blood cancer drug, with COVID-19 partly to blame
badams
Thu, 01/28/2021 – 08:38

from FierceBiotech: Biotech https://ift.tt/3r5EYBb